Effectiveness of amantadine in reducing relapses in multiple sclerosis
- PMID: 3550084
- PMCID: PMC1290678
- DOI: 10.1177/014107688708000210
Effectiveness of amantadine in reducing relapses in multiple sclerosis
Abstract
Fifty-three patients with multiple sclerosis were assessed in a double-blind multicentre study for the effect of amatadine. The patients were observed in general practices for up to four years. Relapses occurred in 5 of the 24 patients treated with amantadine and in 14 of the 29 placebo-treated patients. Neurological deterioration was not significantly different in the two groups.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
